Bibliography
Perry, M., Stansfeld, P. J., Leaney, J., Wood, C., de Groot, M. J., Leishman, D., Sutcliffe, M. J., & Mitcheson, J. S. (2006). Drug Binding Interactions in the Inner Cavity of hERG Channels: Molecular Insights from Structure-Activity Relationships of Clofilium and Ibutilide Analogs. Molecular Pharmacology, 69(2), 509â519.
References
38
Referenced
73
10.1093/nar/28.1.235
/ Nucleic Acids Res / The Protein Data Bank by Berman (2000)10.1016/S0022-3565(25)24807-8
/ J Pharmacol Exp Ther / Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog by Castle (1991)10.1021/jm0208875
/ J Med Chem / Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers by Cavalli (2002)10.1073/pnas.192367299
/ Proc Natl Acad Sci USA / Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels by Chen (2002)10.1126/science.280.5360.69
/ Science (Wash DC) / The structure of the potassium channel: molecular basis of K+ conduction and selectivity by Doyle (1998)10.1124/jpet.301.2.427
/ J Pharmacol Exp Ther / Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel by Ekins (2002)10.1038/nrd1108
/ Nat Rev Drug Disc / The impact of drug-induced QT interval prolongation on drug discovery and development by Fermini (2003)10.1074/jbc.M310683200
/ J Biol Chem / Physicochemical features of the HERG channel drug binding site by Fernandez (2004)10.1124/mol.60.6.1343
/ Mol Pharmacol / Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K+ channels by Ficker (2001)10.1038/sj.bjp.0705025
/ Br J Pharmacol / Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241 by Gessner (2003)10.1124/mol.65.5.1120
/ Mol Pharmacol / Molecular determinants for high-affinity block of human EAG potassium channels by antiarrhythmic agents by Gessner (2004)10.1111/j.1469-7793.1998.003bi.x
/ J Physiol / Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels by Herzberg (1998)10.1085/jgp.69.4.497
/ J Gen Physiol / Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction by Hille (1977)10.1016/0304-4157(77)90003-X
/ Biochim Biophys Acta / Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels by Hondeghem (1977)10.1006/jmbi.1996.0897
/ J Mol Biol / Development and validation of a genetic algorithm for flexible docking by Jones (1997)10.1016/S0026-895X(24)23126-6
/ Mol Pharmacol / Open channel block of HERG K+ channels by vesnarinone by Kamiya (2001)10.1016/S0092-8674(01)00243-4
/ Cell / Molecular and cellular mechanisms of cardiac arrhythmias by Keating (2001)10.1016/S0026-895X(24)23209-0
/ Mol Pharmacol / Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites by Lees-Miller (2000)10.1038/sj.bjp.0705335
/ Br J Pharmacol / Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652 by Milnes (2003)10.1073/pnas.210244497
/ Proc Natl Acad Sci USA / A structural basis for drug-induced long QT syndrome by Mitcheson (2000)10.1085/jgp.115.3.229
/ J Gen Physiol / Trapping of a methanesulfonanilide by closure of the hERG potassium channel activation gate by Mitcheson (2000){'key': '10.1124/mol.105.016741_bib22', 'first-page': '667', 'article-title': 'Molecular determinants of high-affinity drug binding to HERG channels', 'volume': '6', 'author': 'Mitcheson', 'year': '2003', 'journal-title': 'Curr Opin Drug Disc Dev'}
/ Curr Opin Drug Disc Dev / Molecular determinants of high-affinity drug binding to HERG channels by Mitcheson (2003)10.1016/S0960-894X(03)00196-3
/ Bioorg Med Chem Lett / Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches by Pearlstein (2003)10.1124/mol.104.000117
/ Mol Pharmacol / Structural determinants of HERG channel block by clofilium and ibutilide by Perry (2004)10.1002/med.20019
/ Med Res Rev / QT prolongation through hERG K+ channel blockade: current knowledge and strategies for the early prediction during drug development by Recanatini (2004)10.1006/jmbi.1993.1626
/ J Mol Biol / Comparative protein modelling by satisfaction of spatial restraints by Sali (1993)10.1016/j.bbrc.2004.10.127
/ Biochem Biophys Res Commun / High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656 by Ridley (2004)10.1074/jbc.M200448200
/ J Biol Chem / Molecular determinants of voltage dependent HERG K+ channel block by Sanchez-Chapula (2002)10.1124/mol.63.5.1051
/ Mol Pharmacol / Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain by Sanchez-Chapula (2003)10.1016/0092-8674(95)90340-2
/ Cell / A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel by Sanguinetti (1995)10.1016/j.tips.2005.01.003
/ Trends Pharmacol Sci / Predicting drug-hERG channel interactions that cause acquired long QT syndrome by Sanguinetti (2005)10.1111/j.1469-7793.1999.667ad.x
/ J Physiol / Mutations of the S4–S5 linker alter activation properties of HERG potassium channels expressed in Xenopus oocytes by Sanguinetti (1999)10.1016/S0006-3495(03)70020-4
/ Biophys J / Sequence-function analysis of the K+-selective family of ion channels using a comprehensive alignment and the KcsA channel structure by Shealy (2003)10.1161/01.RES.78.3.499
/ Circ Res / Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides by Spector (1996)10.1016/S0006-3495(01)75904-8
/ Biophys J / Distinct mechanisms of block of Kv1.5 channels by tertiary and quaternary amine clofilium compounds by Steidl (2001)10.1016/S0014-5793(97)01030-2
/ FEBS Lett / Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241 by Suessbrich (1997)10.1006/jmcc.2000.1317
/ J Mol Cell Cardiol / IKr: the hERG channel by Tseng (2001)10.1016/S0165-6147(00)01662-X
/ Trends Pharmacol Sci / HERG K+ channels: friend and foe by Vandenberg (2001)
Dates
Type | When |
---|---|
Created | 19 years, 9 months ago (Nov. 16, 2005, 8:34 p.m.) |
Deposited | 6 months, 2 weeks ago (Feb. 19, 2025, 7 a.m.) |
Indexed | 1 month, 1 week ago (July 28, 2025, 2:52 a.m.) |
Issued | 19 years, 7 months ago (Feb. 1, 2006) |
Published | 19 years, 7 months ago (Feb. 1, 2006) |
Published Print | 19 years, 7 months ago (Feb. 1, 2006) |
@article{Perry_2006, title={Drug Binding Interactions in the Inner Cavity of hERG Channels: Molecular Insights from Structure-Activity Relationships of Clofilium and Ibutilide Analogs}, volume={69}, ISSN={0026-895X}, url={http://dx.doi.org/10.1124/mol.105.016741}, DOI={10.1124/mol.105.016741}, number={2}, journal={Molecular Pharmacology}, publisher={Elsevier BV}, author={Perry, Matthew and Stansfeld, Phillip J. and Leaney, Joanne and Wood, Claire and de Groot, Marcel J. and Leishman, Derek and Sutcliffe, Michael J. and Mitcheson, John S.}, year={2006}, month=feb, pages={509–519} }